An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin-Reference-Cited by-同舟云学术

An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin

Published:2006-04 Issue:4 Volume:6 Page:647-655
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Ryan Mary H.,Heavner George A.,Brigham-Burke Michael,McMahon Frank,Shanahan Mary F.,Gunturi Srinivas R.,Sharma Basant,Farrell Francis X.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference20 articles.

1. Bioequivalence and the immunogenicity of biopharmaceuticals;Schellekens;Nat Rev Drug Disc,2002

2. Animal models as indicators of immunogenicity of therapeutic proteins in humans;Bussiere,2003

3. Immunogenicity of rDNA-derived pharmaceuticals;Ryff;Trends Pharm Sci,2002

4. Technical investigations into the cause of the increased incidence of antibody-mediated pure red cell aplasia associated with EPREX®;Sharma;Eur J Hosp Pharm,2004

5. Cellular and molecular immunology;Abbas,2003

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical proteins at the interfaces and the role of albumin;Biotechnology Progress;2024-04-22

2. Behavior of surfactants during processing;Surfactants in Biopharmaceutical Development;2023

3. Identification of an Oxidizing Leachable from a Clinical Syringe Rubber Stopper;Journal of Pharmaceutical Sciences;2021-10

4. Acquired pure red cell aplasia and recombinant erythropoietin;Indian Journal of Nephrology;2021

5. Approval of biosimilars: a review of unsuccessful regulatory filings;Expert Opinion on Biological Therapy;2020-09-04